Jennifer Deason - 25 Mar 2026 Form 4 Insider Report for Concentrix Corp (CNXC)

Reporting relationship: Director
Issuer ticker: CNXC
Reported as of: 25 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Mar 2026, 08:50:27 UTC
Prior SEC filing: 04 Sep 2025
Next SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Farwig, Attorney-in-Fact

Key filing fact

Jennifer Deason filed Form 4 for Concentrix Corp (CNXC) on 27 Mar 2026.

Key facts

This page summarizes Jennifer Deason's Form 4 filing for Concentrix Corp (CNXC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Mar 2026, 08:50.

Change

Previous filing in this sequence was filed on 04 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001679060 Primary reporting owner

Deason Jennifer

Relationship: Director
Address: 39899 BALENTINE DRIVE, NEWARK
Signature: /s/ Andrew Farwig, Attorney-in-Fact
Signature date: 27 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNXC transaction

Common Stock

Award

Transaction value
Shares: +7,701
Change %: +77%
Price: $0.000000^*
Shares after: 17,704
Date: 25 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2027 Annual Meeting of Stockholders.